Response to: Correspondence on “Beta-blockers and renin-angiotensin system inhibitors for Takotsubo syndrome recurrence: a network meta-analysis” by John E Madias
[...]there are no data from randomised trials in Takotsubo syndrome (TTS); second, there is paucity of data on drug dose regimens at follow-up, and, third, patients receiving beta-blockers (BB) and/or renin–angiotensin system inhibitors (RASi) could have a more severe clinical phenotype. [...]given...
Gespeichert in:
Veröffentlicht in: | Heart (British Cardiac Society) 2023-12, Vol.109 (23), p.1795-1796 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!